title: Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors.
abstract: The current standard of care for newly diagnosed glioblastoma multiforme (GBM) is resection followed by radiotherapy with concomitant and adjuvant temozolomide. Recent studies suggest that nearly half of the patients with early radiological deterioration post treatment do not suffer from tumor recurrence but from pseudoprogression. Similarly, a significant number of patients with brain metastases suffer from radiation necrosis following radiation treatments. Conventional MRI is currently unable to differentiate tumor progression from treatment-induced effects. The ability to clearly differentiate tumor from non-tumoral tissues is crucial for appropriate patient management. Ten patients with primary brain tumors and 10 patients with brain metastases were scanned by delayed contrast extravasation MRI prior to surgery. Enhancement subtraction maps calculated from high resolution MR images acquired up to 75 min after contrast administration were used for obtaining stereotactic biopsies. Histological assessment was then compared with the pre-surgical calculated maps. In addition, the application of our maps for prediction of progression was studied in a small cohort of 13 newly diagnosed GBM patients undergoing standard chemoradiation and followed up to 19.7 months post therapy. The maps showed two primary enhancement populations: the slow population where contrast clearance from the tissue was slower than contrast accumulation and the fast population where clearance was faster than accumulation. Comparison with histology confirmed the fast population to consist of morphologically active tumor and the slow population to consist of non-tumoral tissues. Our maps demonstrated significant correlation with perfusion-weighted MR data acquired simultaneously, although contradicting examples were shown. Preliminary results suggest that early changes in the fast volumes may serve as a predictor for time to progression. These preliminary results suggest that our high resolution MRI-based delayed enhancement subtraction maps may be applied for clear depiction of tumor and non-tumoral tissues in patients with primary brain tumors and patients with brain metastases.
authors.affiliation: Oncology Institute, Sheba Medical Center, Ramat-Gan, Israel.
authors.forename: Leor
authors.initials: L
authors.lastname: Zach
authors.forename: David
authors.initials: D
authors.lastname: Guez
authors.forename: David
authors.initials: D
authors.lastname: Last
authors.forename: Dianne
authors.initials: D
authors.lastname: Daniels
authors.forename: Yuval
authors.initials: Y
authors.lastname: Grober
authors.forename: Ouzi
authors.initials: O
authors.lastname: Nissim
authors.forename: Chen
authors.initials: C
authors.lastname: Hoffmann
authors.forename: Dvora
authors.initials: D
authors.lastname: Nass
authors.forename: Alisa
authors.initials: A
authors.lastname: Talianski
authors.forename: Roberto
authors.initials: R
authors.lastname: Spiegelmann
authors.forename: Zvi R
authors.initials: ZR
authors.lastname: Cohen
authors.forename: Yael
authors.initials: Y
authors.lastname: Mardor
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000556:secondary* / Q000601:surgery; D003287:Contrast Media; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis
chemical_list: D003287:Contrast Media